Penumbra, Inc. (PEN)
321.68
+0.68
(+0.21%)
USD |
NYSE |
Aug 28, 16:00
321.68
0.00 (0.00%)
After-Hours: 20:00
Penumbra Free Cash Flow : 215.91M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 215.91M |
| March 31, 2026 | 212.73M |
| December 31, 2025 | 174.93M |
| September 30, 2025 | 152.62M |
| June 30, 2025 | 161.62M |
| March 31, 2025 | 150.33M |
| December 31, 2024 | 147.30M |
| September 30, 2024 | 134.18M |
| June 30, 2024 | 110.67M |
| March 31, 2024 | 105.36M |
| December 31, 2023 | 82.12M |
| September 30, 2023 | 47.28M |
| June 30, 2023 | 0.51M |
| March 31, 2023 | -56.25M |
| December 31, 2022 | -74.96M |
| September 30, 2022 | -90.10M |
| June 30, 2022 | -40.19M |
| March 31, 2022 | -2.79M |
| December 31, 2021 | -11.68M |
| September 30, 2021 | -0.152M |
| June 30, 2021 | -38.50M |
| March 31, 2021 | -60.31M |
| Date | Value |
|---|---|
| December 31, 2020 | -58.00M |
| September 30, 2020 | -55.38M |
| June 30, 2020 | -33.54M |
| March 31, 2020 | -6.977M |
| December 31, 2019 | 4.543M |
| September 30, 2019 | 12.25M |
| June 30, 2019 | 7.105M |
| March 31, 2019 | 6.789M |
| December 31, 2018 | 19.20M |
| September 30, 2018 | 8.08M |
| June 30, 2018 | 5.906M |
| March 31, 2018 | 6.544M |
| December 31, 2017 | -2.341M |
| September 30, 2017 | -12.62M |
| June 30, 2017 | -17.08M |
| March 31, 2017 | -22.74M |
| December 31, 2016 | -26.44M |
| September 30, 2016 | -20.14M |
| June 30, 2016 | -28.23M |
| March 31, 2016 | -28.49M |
| December 31, 2015 | -27.75M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.625B |
| Globus Medical, Inc. | 750.84M |
| Teleflex, Inc. | 339.77M |
| Abbott Laboratories | 7.824B |
| AngioDynamics, Inc. | -2.86M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 46.08M |
| Cash from Investing (Quarterly) | -91.09M |
| Cash from Financing (Quarterly) | 9.025M |
| Free Cash Flow Per Share (Quarterly) | 0.8223 |
| Free Cash Flow to Equity (Quarterly) | 36.01M |
| Free Cash Flow to Firm (Quarterly) | 32.78M |
| Free Cash Flow Yield | 1.70% |